Trentina Di Muccio Selected Research

Pentamidine (NebuPent)

8/2020

Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Trentina Di Muccio Research Topics

Disease

7	Leishmaniasis 01/2024 - 03/2011
3	Infections 02/2020 - 10/2014
1	Ulcer 01/2021
1	Mucocutaneous Leishmaniasis 08/2020
1	Hypersensitivity (Allergy) 12/2019
1	HIV Infections (HIV Infection) 12/2019
1	Spotted Fever Group Rickettsiosis (Rickettsialpox) 05/2019
1	Visceral Leishmaniasis (Kala Azar) 09/2008
1	Acute Kidney Injury (Acute Renal Failure) 09/2008
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 09/2008

Drug/Important Bio-Agent (IBA)

4	liposomal amphotericin B FDA Link 01/2021 - 09/2008
3	trypanothione reductaseIBA 01/2024 - 11/2018
3	EnzymesIBA 12/2022 - 11/2018
2	Meglumine AntimoniateIBA 01/2021 - 08/2020
2	tryparedoxinIBA 02/2020 - 11/2018
2	tryparedoxin peroxidaseIBA 02/2020 - 11/2018
2	trypanothioneIBA 02/2020 - 11/2018
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2020 - 11/2018
1	AzolesIBA 08/2020
1	Pentamidine (NebuPent)FDA LinkGeneric 08/2020
1	Sulfides (Thioethers)IBA 02/2020
1	miltefosine (Impavido)IBA 12/2019
1	DNA (Deoxyribonucleic Acid)IBA 05/2019
1	Leishmaniasis VaccinesIBA 10/2014
1	VaccinesIBA 10/2014
1	SilverIBA 03/2011
1	AntimonyIBA 03/2011

Therapy/Procedure

1	Therapeutics 01/2021